P

Inventor

FINKELSTEIN JOSEPH A

US11 patents
⚠️ This page may combine multiple inventors who share the name “FINKELSTEIN JOSEPH A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SMITHKLINE BECKMAN CORP

5 patents
US4835154AMay 30, 1989

1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors

SMITHKLINE BECKMAN CORP10 citations73
US4859779AAug 22, 1989

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP3 citations61
US4762850AAug 9, 1988

Dopamine-beta-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP2 citations61
US4761415AAug 2, 1988

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP3 citations61
US4837353AJun 6, 1989

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BECKMAN CORP1 citations50

SMITHKLINE BEECHAM CORP

3 patents
US5185351AFeb 9, 1993

Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists

SMITHKLINE BEECHAM CORP119 citations97
US5418250AMay 23, 1995

Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists

SMITHKLINE BEECHAM CORP14 citations73
US4992459AFeb 12, 1991

Dopamine-β-hydroxylase inhibitors

SMITHKLINE BEECHAM CORP4 citations61

FINKELSTEIN JOSEPH A

2 patents
US5312828AMay 17, 1994

Substituted imidazoles having angiotensin II receptor blocking activity

FINKELSTEIN JOSEPH A37 citations90
US5234917AAug 10, 1993

Substituted 5-(alkyl)carboxamide imidazoles

FINKELSTEIN JOSEPH A23 citations89

SMITHKLEIN BECKMAN CORP

1 patent
US4628059ADec 9, 1986

Dopamine-β-hydroxylase inhibitors

SMITHKLEIN BECKMAN CORP4 citations57